Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

National Pediculosis Association Urges Centers for Disease Control to Act Promptly on Reviewing and Updating its Information on Treating Children with Head Lice

Because parents and school health professionals rely heavily on CDC's guidance, it is imperative that CDC's information be kept as current and accurate as possible.


News provided by

National Pediculosis Association

Sep 22, 2020, 06:00 ET

Share this article

Share toX

Share this article

Share toX

NPA's popular teaching tool showing people what to look for, encouraging them to screen regularly for head lice and nits -- early detection is the best prevention!
NPA's popular teaching tool showing people what to look for, encouraging them to screen regularly for head lice and nits -- early detection is the best prevention!

NEWTON, Mass., Sept. 22, 2020 /PRNewswire-PRWeb/ -- The COVID-19 pandemic has been a striking reminder of the need for preparedness regarding public health issues. As children return to school and other group settings in this challenging environment, the National Pediculosis Association (NPA) wants to minimize pediculosis (head lice) as an additional burden by ensuring that parents have access to public health information that is current, accurate and trustworthy.

To this end, NPA reviewed the website guidance on head lice published by the Centers for Disease Control and Prevention (CDC) and identified a number of concerns. In June 2020, NPA submitted these concerns to CDC and requested that, as the US authority on communicable diseases, CDC reexamine its advice on pediculosis. NPA's concerns are:

There's a critical difference between treating lice and treating a child infested with lice.

Post this
  • CDC focuses on reactive checking and treatment without mentioning the value of proactive screening for head lice
  • CDC omits combing as a diagnostic screening method
  • The treatment options provided by CDC are limited to chemical treatments only
  • The language used by CDC when discussing chemical treatments does not adequately warn parents of the potential danger associated with chemical treatments
  • The source of CDC's information on pediculicide products is not disclosed nor validated as impartial and unaffiliated with product manufacturers
  • Unlike the Food and Drug Administration (FDA), CDC does not acknowledge combing as a valid non-chemical alternative to the use of pesticide treatments
  • CDC uses language that is overly technical and complicated
  • CDC inaccurately rules out head lice as a vector of disease
  • CDC concludes that "Head lice should not be considered as a medical or public health hazard" which conflicts with its own recommendations to use pesticide treatments which are themselves medical and public health hazards and ignores that head lice are communicable parasites.

CDC responded that the agency "regularly reviews and updates [its] web pages," would "share [NPA's] concerns with its subject matter experts," and would "consider [NPA's] suggestions when [it] next update[s] the pages." CDC further explained, "CDC's head lice resources were last updated in summer 2019" and "are scheduled to be reviewed (and updated, as necessary) as part of a routine three-year review cycle in summer 2022. We also review/update pages on an ad hoc basis."

While appreciating the demands of the current public health environment under COVID-19, NPA urges CDC to act promptly on reviewing and updating its information on head lice, rather than waiting for the agency's regular scheduled review. Because parents and school health professionals rely heavily on CDC's guidance, it is imperative that it be kept as current and accurate as possible.

When a child has head lice, parents and others shouldn't have to wait for sound treatment advice from the authorities they rely on. Now – in September, which is Head Lice Prevention Month – is the perfect time for CDC to take action to ensure that its published advice on head lice is thorough, accurate, parent-friendly and up to date.

"Because it's not about lice, it's about kids."

The National Pediculosis Association,® Inc. Mission Statement:
The NPA is a 501(c)(3) non-profit organization dedicated since 1983 to protecting children, their families and their environment from the misuse and abuse of prescription and over-the-counter pesticide treatments for lice and scabies.

Pediculosis (the medical term for an infestation of lice) provides a public health opportunity to teach important lessons about communicable disease preparedness, responsible personal behaviors, environmental health, and the importance of learning about pharmaceutical remedies before using them on our children and ourselves.

NPA is committed to setting the highest possible public health standards for children as they relate to the communicability and treatment of head lice. NPA has been the leader in raising pediculosis as a public health priority and a pioneer in public health education and research on pediculosis.

The NPA developed the LiceMeister® comb in 1997 to accomplish its mission by providing a higher standard for lice combing tools and a safe, cost-effective treatment alternative to pesticides. All proceeds from sales of the LiceMeister comb allow the NPA to be self-sustaining and independent from product manufacturers.

The National Pediculosis Association,® Inc. (NPA)
1005 Boylston Street / STE 343
Newton, MA 02461
617-905-0176 / [email protected]
Connect with us!

SOURCE National Pediculosis Association

Related Links

https://www.headlice.org/comb/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.